about
Acute alcohol response phenotype in heavy social drinkers is robust and reproducibleNeural substrates of cue reactivity: association with treatment outcomes and relapseThe Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.Varenicline potentiates alcohol-induced negative subjective responses and offsets impaired eye movements.Acute HPA axis response to naltrexone differs in female vs. male smokers.The relationship between methamphetamine and alcohol use in a community sample of methamphetamine users.Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial.Modeling naturalistic craving, withdrawal, and affect during early nicotine abstinence: A pilot ecological momentary assessment study.Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers.Sex differences in acute hormonal and subjective response to naltrexone: The impact of menstrual cycle phaseFactor Structure of Subjective Responses to Alcohol in Light and Heavy Drinkers.Alcohol impairment of saccadic and smooth pursuit eye movements: impact of risk factors for alcohol dependenceCurrent insights into the mechanisms and development of treatments for heavy drinking cigarette smokersHormonal contraceptive use diminishes salivary cortisol response to psychosocial stress and naltrexone in healthy womenA Pilot Study of the Safety and Initial Efficacy of Ivermectin for the Treatment of Alcohol Use Disorder.Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient studyOpportunities for the development of neuroimmune therapies in addiction.Subjective response as a consideration in the pharmacogenetics of alcoholism treatment.Subjective Response to Alcohol as a Research Domain Criterion.Relationship between negative affect and smoking topography in heavy drinking smokers.Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder.Predictors of smoking lapse in a human laboratory paradigm.Differences between treatment-seeking and non-treatment-seeking participants in medication studies for alcoholism: do they matter?Pharmacogenetic Effects of Naltrexone in Individuals of East Asian Descent: Human Laboratory Findings from a Randomized Trial.Subjective responses to alcohol: a paradigm shift may be brewing.Differences in the subjective and motivational properties of alcohol across alcohol use severity: application of a novel translational human laboratory paradigmOvercoming the "Valley of Death" in Medications Development for Alcohol Use DisorderDistress Tolerance and Craving for Cigarettes Among Heavy Drinking SmokersAlcohol, tobacco, and marijuana consumption is associated with increased odds of same-day substance co- and tri-useNaltrexone effects on subjective responses to alcohol in the human laboratory: A systematic review and meta-analysisLack of Association between Opioid-Receptor Genotypes and Smoking Cessation Outcomes in a Randomized, Controlled Naltrexone Trial
P50
Q24289152-93DC28BF-155B-47A9-A501-BD810CDAD518Q26782278-AA2A57E4-8C57-462C-A0F7-6E4FACC30F1BQ27310644-0E3A5942-FBF6-4C22-9385-A9A0A9E7C4F5Q30454909-3FF26D18-81AC-48DA-BDE1-36446398E54BQ33746448-AB001311-C4DB-4F7D-8A0B-EF2D38A752A1Q34149087-49807B33-FDB5-4E2A-8C7B-E886AABC172BQ34549370-2332E380-9619-4307-9FB2-13C705D73900Q35298102-88E5D946-A2C0-4191-9924-18282335DDB2Q35689017-392FAD92-5405-4D16-B816-21BE38D8D9A7Q35786999-8BD1AE85-2E1C-4637-9CE5-89ADAB3D1B16Q35815792-C57B8A63-8610-4428-95B6-561230757EF3Q36249198-722028BF-3C3E-4815-8F67-E0B52DFA5A4FQ36877440-74088BC9-F0DB-49DC-86CC-D634413B3DEDQ36933009-62B872D4-4390-43B3-83BD-97BEFD09E87AQ37088573-AD6CB187-670E-4151-B5D0-62ACC299D7B4Q37698675-9A881372-C25E-4095-8D74-50F552E7B38AQ38245115-E9B02682-A171-4B70-A633-CB0185BAC9BAQ38464015-2764104A-B1E4-4956-9AAA-DC934612F639Q38685941-65795C1C-11FF-41C8-BAB1-5B90A6CD920AQ38860859-7AD41220-61D0-489C-84EB-21A8A29BEFB0Q38867904-99C34FC9-B16D-4075-A08B-B38C748CE458Q39255477-87B6B6D9-CD10-4DAD-9ABD-DE693A67B0FAQ46002465-21DE8E62-E487-4773-9B3B-A6A54513F4FDQ47674472-168A190B-2C72-437C-A42C-784333FDDF56Q51678555-777FBDF0-453D-4809-A01F-19D7ED14C0C8Q57173271-FC34E3BF-18E5-4DEE-8A7C-DB0053CC1442Q89402756-F1986BCF-2657-4C75-AEC2-662B91208322Q90677146-1391DEA7-3B54-4BAE-9304-D4DFF1209C7DQ91994135-67E7F9E7-581F-441B-85CD-60F9E7287CD4Q92425410-642699AC-48A3-46A0-A6D2-99D3ECB76385Q92801037-62550A1C-54A4-43FA-85FD-75FFDBBD6B5C
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Daniel Roche
@ast
Daniel Roche
@en
Daniel Roche
@es
Daniel Roche
@nl
Daniel Roche
@sl
دانييل روش
@ar
type
label
Daniel Roche
@ast
Daniel Roche
@en
Daniel Roche
@es
Daniel Roche
@nl
Daniel Roche
@sl
دانييل روش
@ar
prefLabel
Daniel Roche
@ast
Daniel Roche
@en
Daniel Roche
@es
Daniel Roche
@nl
Daniel Roche
@sl
دانييل روش
@ar
P106
P1153
36151397100
P21
P31
P496
0000-0001-6298-1519